Merck & Co., Inc.



contact icon Contact Corporate Responsibility
survey icon Take our Survey
email icon E-mail a Friend/Colleague

GARDASIL ® Access Program

Advancing the Dialogue Toward a Healthier Future

Overview Approach Performance Priorities & Goals

In September 2008, the Advisory Board recommended, and AHD later approved, eight organizations and institutions as the first recipients of GARDASIL through this donation program. Over 195,000 doses of GARDASIL were approved for donation to these eight applicants based in Bolivia, Cambodia, Ghana, Haiti, India, Lesotho, Nepal and Nicaragua. The first shipments of donated GARDASIL were sent to Bolivia, Cambodia, and Lesotho during the first half of 2009.

 

 

 

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.

Printer Friendly Page
 

Quick Links


World Map of Key Activities  

Merck Links

RESOURCES

 Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap